Kolexia
Lachaier Emma
Oncologie médicale
Centre Hospitalier D'Amiens Salouël Site Sud
Salouël, France
29 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs du sein Nécrose Carcinome épidermoïde Tumeurs de la tête et du cou Leucémies Tumeurs du foie Carcinome hépatocellulaire Leucémie aigüe myéloïde

Industries

Ipsen
4 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2022
Novartis
2 collaboration(s)
Dernière en 2021
AstraZeneca
2 collaboration(s)
Dernière en 2023

Dernières activités

Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authorization for use (cATU) program in France
2021 San Antonio Breast Cancer Symposium   15 février 2022
Abstract P1-18-16: First line aromatase inhibitor (AI) + palbociclib with randomized switch to fulvestrant + palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Global safety results of PADA-1, a UCBG-GINECO phase III trial
2021 San Antonio Breast Cancer Symposium   15 février 2022
Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: Results of PADA-1, a UCBG-GINECO randomized phase 3 trial
2021 San Antonio Breast Cancer Symposium   15 février 2022
Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults.
HemaSphere   23 mars 2021
Thrombotic Microangiopathy Revealing Bone Metastases from an Ethmoid Sinus Carcinoma.
Case reports in oncology   17 août 2016
Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies.
BMC cancer   16 avril 2016
Personalization of the medical treatment of solid tumours using patient-derived tumour explants (Review).
International journal of oncology   18 janvier 2016
Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
Anticancer research   09 janvier 2015
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells.
Cancer letters   12 novembre 2014
Ferroptosis, a new form of cell death relevant to the medical treatment of cancer.
Medecine sciences : M/S   01 septembre 2014